Cogent Biosciences, Inc. (COGT)
NASDAQ · Healthcare
Cogent Biosciences, Inc. Cash on Hand 2017–2020
Cogent Biosciences, Inc. annual/quarterly cash on hand history from 2017 to 2020. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Cogent Biosciences, Inc. cash on hand for the quarter ending December 31, 2020 were 242.2M, a 547.15% increase year-over-year.
- Cogent Biosciences, Inc. cash on hand for 2020 were 242.2M, a 547.15% increase from 2019.
- Cogent Biosciences, Inc. cash on hand for 2019 were 37.4M, a 32.78% decrease from 2018.
- Cogent Biosciences, Inc. cash on hand for 2018 were 55.7M, a 96.93% increase from 2017.
- Cogent Biosciences, Inc. cash on hand for 2017 were 28.3M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cogent Biosciences, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2020 | $242 |
| 2019 | $37 |
| 2018 | $56 |
| 2017 | $28 |
| Cogent Biosciences, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2020-12-31 | $242 |
| 2019-12-31 | $37 |
| 2018-12-31 | $56 |
| 2017-12-31 | $28 |
Cogent Biosciences, Inc. Cash on Hand — FAQ
Cogent Biosciences, Inc. (COGT) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COGT's cash on hand history?
The chart and table above show Cogent Biosciences, Inc.'s cash on hand by year and by quarter, including the growth rate.